BSPED2019 ORAL COMMUNICATIONS Oral Communications 2 (2 abstracts)
National United Kingdom evidence- and consensus-based guidelines for the investigation, treatment and long-term follow-up of paediatric craniopharyngioma
Hoong-Wei Gan 1 , Paul Morillon 2 , Assunta Albanese 3 , Kristian Aquilina 4 , Konstantinos Barkas 5 , Chris Chandler 5 , Yen-Ch’ng Chang 6 , Christina Daousi 7 , Evangelos Drimtzias 8 , Sarah Farndon 9 , Tom Jacques 1 , Marta Korbonits 10 , Adam Kuczynski 4 , Jennifer Limond 11 , Louise Robinson 12 , Ian Simmons 8 , Nick Thomas 5 , Sophie Thomas 13 , Nicola Thorpe 14 , Faraneh Vargha-Khadem 1 , Daniel Warren 8 , Bassel Zebian 5 , Ashley Gamble 15 , Sophie Wilne 13 , Barney Harrison 16 , Helen Spoudeas 4 & Conor Mallucci 17
1UCL Great Ormond Street Institute of Child Health, London, UK; 2Imperial College Healthcare NHS Trust, London, UK; 3St. George’s University Hospitals NHS Foundation Trust, London, UK; 4Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 5King’s College Hospital NHS Foundation Trust, London, UK; 6University College London Hospitals NHS Foundation Trust, London, UK; 7University of Liverpool, Liverpool, UK; 8The Leeds Teaching Hospitals NHS Trust, Leeds, UK; 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; 10Queen Mary University of London, London, UK; 11University of Glasgow, Glasgow, UK; 12Manchester University NHS Foundation Trust, Manchester, UK; 13Nottingham University Hospitals NHS Trust, Nottingham, UK; 14The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; 15Children’s Cancer and Leukaemia Group, Leicester, UK; 16Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; 17Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
Aims: Although rare, craniopharyngiomas are the commonest suprasellar tumour in childhood. Despite high overall survival, children and young people <19 years with craniopharyngiomas are at risk of multiple relapses and long-term tumour- and treatment-related morbidity. We sought to provide, for the first time, a national standard for best practice based on currently available evidence for the assessment, treatment and follow-up of paediatric craniopharyngiomas under the auspices of the RCPCH, UK CCLG and BSPED.
Methods: Clinical questions were formulated based on a PICO (Population, Intervention, Comparison, Outcome) format by a multidisciplinary Guideline Development Group. Systematic searches were conducted via the Ovid MEDLINE (1946-February 2017) and Cochrane Library (2016, Issue 12) databases, identifying 2023 separate research articles. Publications underwent a three-tier filtering process and 300 were reviewed using the GRADE approach. Where recommendations could not be made, a two-stage international Delphi consensus process was conducted. The guideline was developed using AGREE II criteria.
Results: 44 clinical questions were identified, leading to 35 recommendations largely based on low to very low quality evidence. 30 further recommendations achieved >70% agreement via the Delphi consensus process. Important highlights include the recommendation that craniopharyngiomas are managed in tertiary paediatric centres with sufficient neuro-oncology, neurosurgery, endocrinology, radiology, pathology and neuropsychology multidisciplinary experience. At diagnosis, tumours should be graded using the ‘Paris’ grading system (Puget et al., J Neurosurg 2007; 106(Suppl 1):3–12) and subsequent surgical treatment tailored to avoid hypothalamic damage, with adjuvant upfront radiotherapy being offered where tumour resection is incomplete. Detailed recommendations on the neuroendocrine, ophthalmological and psychological pre-treatment assessment of patients and long-term follow-up of survivors are also made, with a review on the safety of growth hormone replacement therapy in this cohort.
Conclusions: These guidelines provide the first evidence- and consensus-based national recommendations for the management of paediatric craniopharyngioma, and highlight the need for further research in areas such as the efficacy of proton beam therapy, radiosurgery and intracystic therapies in children, and the management of late effects such as hypothalamic obesity. Through their implementation, we hope to achieve better consistency in the quality of care of such patients and improve long-term quality of survival.
Volume 66
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more